Litfulo

Litfulo is an oral treatment for adults and adolescents aged 12 and older with severe alopecia areata. It helps regrow scalp hair by blocking immune pathways that attack hair follicles.

Molecule Details :

  • Molecule Name :

    Ritlecitinib
  • Innovator :

    PFIZER INC
  • Approval Date :

    23-Jun-23
  • NCE-1 Date :

    23-Jun-27
  • Dosage Form :

    Capsule
  • Strength :

    50MG
  • Therapeutic Category :

    Immunomodulators
  • Revenue ($M) :

    NA

Year-wise Projected Sales ($M) :

  • 2025 :

    119
  • 2026 :

    185
  • 2027 :

    264
  • 2028 :

    350
  • 2029 :

    423
  • 2030 :

    489
  • 2031 :

    540
Looking for this molecule for your next clinical research? Access regulatory-compliant comparators with assured timelines—delivered reliably through our global network.

Why Choose Spring Bio Solution?

Supported 1000+ Clinical Trials globally

Provides services across regulatory, legal & clinical research

Unmatched intelligence on batches, expiry, spacing, and historical data from innovators

Integrated CRO Services as part of our offerings

Insights on global pricing for smarter clinical trial supply decisions 


Login NCE Grid

Register NCE Grid

Are you sure want to logout from NCE Grid?